GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Cyclically Adjusted Book per Share

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Cyclically Adjusted Book per Share : $11.75 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted book value per share for the three months ended in Dec. 2023 was $14.923. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $11.75 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Takeda Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 6.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 4.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Takeda Pharmaceutical Co was 4.00% per year. The lowest was 1.30% per year. And the median was 1.70% per year.

As of today (2024-04-27), Takeda Pharmaceutical Co's current stock price is $13.03. Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $11.75. Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.11.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Takeda Pharmaceutical Co was 2.42. The lowest was 1.03. And the median was 1.40.


Takeda Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.48 12.94 13.01 12.07 12.03

Takeda Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.93 12.03 11.22 10.98 11.75

Competitive Comparison of Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Takeda Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Takeda Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=14.923/106.8000*106.8000
=14.923

Current CPI (Dec. 2023) = 106.8000.

Takeda Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201403 15.290 95.700 17.063
201406 14.822 98.000 16.153
201409 14.525 98.500 15.749
201412 13.286 97.900 14.494
201503 11.293 97.900 12.320
201506 11.134 98.400 12.084
201509 11.220 98.500 12.165
201512 10.974 98.100 11.947
201603 11.011 97.900 12.012
201606 10.955 98.100 11.927
201609 11.403 98.000 12.427
201612 10.899 98.400 11.829
201703 10.742 98.100 11.695
201706 11.627 98.500 12.607
201709 12.051 98.800 13.027
201712 11.978 99.400 12.870
201803 12.054 99.200 12.977
201806 11.882 99.200 12.792
201809 12.379 99.900 13.234
201812 11.628 99.700 12.456
201903 14.994 99.700 16.062
201906 14.493 99.800 15.510
201909 14.523 100.100 15.495
201912 14.334 100.500 15.233
202003 14.081 100.300 14.994
202006 13.936 99.900 14.899
202009 14.122 99.900 15.097
202012 14.283 99.300 15.362
202103 15.221 99.900 16.272
202106 15.164 99.500 16.277
202109 15.364 100.100 16.392
202112 15.035 100.100 16.041
202203 15.365 101.100 16.231
202206 15.249 101.800 15.998
202209 15.069 103.100 15.610
202212 14.724 104.100 15.106
202303 15.290 104.400 15.641
202306 15.747 105.200 15.986
202309 15.241 106.200 15.327
202312 14.923 106.800 14.923

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Takeda Pharmaceutical Co  (NYSE:TAK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=13.03/11.75
=1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Takeda Pharmaceutical Co was 2.42. The lowest was 1.03. And the median was 1.40.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Takeda Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Headlines

From GuruFocus